Moving an LBP Through the Clinic & Into Commercial Manufacturing – The CDMOs Perspective!

Time: 12:00 pm
day: Conference Day One Track C AM 1


  • Outlining Biose’s History and why Biose is already moving into Phase III with pure LBP projects- the advantages of a one stop single site solution. 
  • Discussing nearly 40 clinical lines for every conceivable LBP option: anaerobic, GMO, multi and single strains, exploring numerous drug, product solutions, encapsulation, sachets,liquids and oils and tablets
  • A full breakdown of running an LBP CMC program